What is the best course of action for a patient with end-stage renal disease (ESRD), pulmonary edema, and cardiac strain, who has a history of missing dialysis appointments due to transportation issues and has been hospitalized multiple times, currently taking medications including losartan (angiotensin II receptor antagonist), atorvastatin (HMG-CoA reductase inhibitor), and metoprolol succinate (beta blocker), and presenting with normal vital signs, but requiring ongoing dialysis and oxygen therapy at 3L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Priority: Establish Reliable Dialysis Access Through Facility Transfer

This patient requires immediate transfer to a dialysis facility with in-house transportation services or consideration for home dialysis modalities, as transportation failure is directly causing life-threatening complications including pulmonary edema with cardiac strain (elevated troponin) and encephalopathy. 1

Critical Context: Transportation Barriers and Mortality Risk

  • Transportation failure represents the most common barrier to dialysis attendance and is associated with a 3.98-fold increased risk of hospitalization within 2 days of a missed treatment 1
  • Missed dialysis treatments directly increase mortality risk (HR 1.68), cardiovascular mortality, sudden death/cardiac arrest, and hospitalization rates 2
  • The pattern of recurrent hospitalizations from missed dialysis demonstrates that current transportation arrangements have failed catastrophically and will continue to fail without systemic intervention 1

Primary Recommendation: Facility Transfer with Integrated Transportation

Transfer this patient to a dialysis center that provides reliable in-house transportation services as the definitive solution. 3

Implementation Steps:

  • Identify dialysis facilities in the region with dedicated transportation programs before discharge 3
  • Coordinate with social work to arrange facility transfer within 1 week
  • Document that current transportation arrangements have resulted in multiple life-threatening hospitalizations requiring immediate intervention 1
  • Ensure accepting facility has capacity and willingness to manage this patient's complex medical needs including oxygen requirements 3

Alternative: Home Dialysis Modalities

If facility transfer with transportation is unavailable, peritoneal dialysis represents the superior alternative for this patient. 3

Rationale for Peritoneal Dialysis:

  • Eliminates transportation barriers entirely by allowing home-based treatment 3
  • Provides more gradual fluid removal with smaller hemodynamic shifts, reducing risk of hypotension and cardiac strain 3
  • Avoids repeated ischemic insults to organs compared to intermittent hemodialysis 3
  • Reduces hospitalization days when properly managed 3

Prerequisites for Home Dialysis:

  • Patient must demonstrate cognitive capacity (currently A&O x4) and physical ability to perform exchanges 3
  • Requires supportive home dialysis program willing to train and monitor patient 3
  • Need assessment of home environment and caregiver availability 3
  • Patient must understand that missing peritoneal dialysis exchanges carries similar mortality risk as missed hemodialysis 4

Medication Management During Transition

Continue current cardiovascular medications but implement monthly medication reconciliation per CMS requirements. 3

Critical Medication Considerations:

  • Losartan 50mg: Monitor renal function closely as ARBs can worsen kidney function in volume-depleted states; however, discontinuation is not indicated in stable ESRD on dialysis 5
  • Metoprolol succinate 100mg: Continue for cardiac protection given elevated troponin history 3
  • Sevelamer carbonate 800mg: Verify adherence as phosphate control is essential; inadequate dialysis leads to hyperphosphatemia 2
  • Dialysis patients average 2-3 medication discrepancies per reconciliation; pharmacist involvement improves accuracy 3

Oxygen and Respiratory Management

  • Continue home oxygen at 3L to maintain SpO2 >92% 3
  • Strictly prohibit smoking in apartment as this patient has chronic respiratory failure with hypoxia and history of pulmonary edema
  • Monitor for signs of fluid overload between dialysis sessions (increased oxygen requirement, orthopnea, peripheral edema)

Emergency Education: Non-Negotiable Return Precautions

Educate patient that the following require IMMEDIATE emergency department presentation:

  1. Missing ANY scheduled dialysis session - this is a medical emergency with 3.98x hospitalization risk within 48 hours 1
  2. Altered mental status or worsening confusion (uremic encephalopathy) 6
  3. Severe shortness of breath or chest pain (pulmonary edema, cardiac strain) 3
  4. Inability to maintain oxygen saturation on home oxygen
  5. Muscle weakness, palpitations, or irregular heartbeat (hyperkalemia) 6

Dietary Management

  • Strict low-potassium diet to prevent life-threatening hyperkalemia between dialysis sessions 7
  • Maintain adequate protein intake (1.2 g/kg/day for hemodialysis patients) to prevent malnutrition 7
  • Fluid restriction based on residual urine output and interdialytic weight gain targets 3
  • Phosphate restriction with meals to reduce cardiovascular calcification risk 7

Higher Level of Care Consideration

If transportation and home dialysis options both fail, assisted living facility placement with dialysis transportation services is medically necessary. 1

Justification:

  • Current living situation has resulted in multiple preventable hospitalizations with life-threatening complications
  • Pattern demonstrates inability to access life-sustaining treatment independently
  • Mortality risk increases exponentially with continued missed treatments 2
  • This represents failure of outpatient management requiring escalation of care setting

Common Pitfalls to Avoid

  • Do not assume backup transportation plans will work - this patient has already demonstrated transportation failure; only systemic solutions (facility transfer or home dialysis) will succeed 1
  • Do not delay intervention - each missed treatment carries immediate mortality risk; waiting for "one more chance" with current arrangements is medically inappropriate 1, 2
  • Do not focus solely on laboratory values - this patient's clinical trajectory (recurrent hospitalizations, pulmonary edema, encephalopathy) demonstrates inadequate dialysis regardless of current stable vital signs 7
  • Do not overlook medication reconciliation - ESRD patients average 2-3 medication discrepancies that contribute to hospitalizations; monthly reconciliation is now a CMS quality metric 3

References

Research

Adherence barriers to chronic dialysis in the United States.

Journal of the American Society of Nephrology : JASN, 2014

Research

Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dialysis Fluid Management in End-Stage Renal Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Uremic Encephalopathy in Patients Refusing Dialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Managing ESRD and Uremic Syndrome: Methods to Postpone Dialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

How to manage a patient with lightheadedness on Bendroflumethiazide (thiazide diuretic) and losartan (angiotensin II receptor antagonist) with impaired renal function?
Should irbesartan (Angiotensin II Receptor Blocker) be held in a patient with Acute Kidney Injury (AKI)?
What is the best course of action for an elderly male patient with grade I diastolic dysfunction, Chronic Kidney Disease (CKD) stage 3B, and Alzheimer's disease, who developed hypotension after being prescribed 25mg losartan and having his amlodipine (calcium channel blocker) dose reduced from 10mg to 5mg, despite having a history of average hypertension of 155/90?
What is the best course of action for a patient with essential hypertension, chronic kidney disease, and hyperlipidemia, taking losartan (angiotensin II receptor antagonist) 100 mg per day, presenting with severe hypotension?
What are the next steps for a 56-year-old male with Chronic Kidney Failure (CKF), noncompliant with treatment, presenting with lower extremity edema and hypertension, currently on Carvedilol (Beta Blocker) 6.25 MG, Losartan Potassium (Angiotensin II Receptor Antagonist) 50 MG, and recently started on Lasix (Furosemide) 20mg twice daily?
What is the recommended dosage of ertapenem (a carbapenem antibiotic) for a patient with a positive urinary tract infection (UTI) and potential impaired renal function?
What are the next steps for a 3-year-old male patient with a history of recurrent leg pain, limping, and guarding, who previously presented to the emergency room (ER) with acute onset of inability to weight-bear on his left foot, redness, and mild swelling, but no deformity, and had unremarkable X-rays and labs, and has since tried over-the-counter (OTC) pain relief with acetaminophen (paracetamol) or ibuprofen with some effect, but continues to experience pain and limping, particularly with increased activity, and has developmental delays in communication?
Can Macrobid (nitrofurantoin monohydrate) be used to treat uncomplicated urinary tract infections (UTIs) in adult males with normal renal function and no history of kidney disease?
What is the recommended dose and frequency of Debrox (carbamide peroxide) for a patient with excessive ear wax buildup?
Can Hydrocortisone (hydrocortisone) Solu-Cortef be administered intramuscularly (IM) or subcutaneously (SC) for emergency treatment of adrenal crisis, and which route is recommended?
What is the best approach to diagnose and treat a patient with recurrent muscle cramps and a history of thyroid problems?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.